TCM Group (TCM) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
21 Nov, 2025Executive summary
Q1 2025 revenue grew 5.3% year-over-year to DKK 308.1 million, driven by strong B2C sales and early recovery in Norway.
Organic growth was 3.6%, with positive order intake in both B2C and B2B segments.
Gross margin improved to 21.1% from 20.5%, aided by the acquisition of two Svane Køkkenet stores.
Adjusted EBIT rose to DKK 17.1 million (5.6% margin), up from DKK 15.8 million (5.4% margin) in Q1 2024.
New product launches included AUBO's Truffel and Svane Køkkenet's Notes Bronze.
Financial highlights
Revenue: DKK 308.1 million (+5.3% year-over-year); organic growth 3.6%.
Adjusted EBIT: DKK 17.1 million (margin 5.6%), up from DKK 15.8 million (5.4%).
Gross margin: 21.1% (Q1 2024: 20.5%).
Free cash flow: DKK -3.7 million, down from DKK 12.6 million.
Net debt: DKK 332.2 million, leverage ratio down to 2.6 from 3.7.
Outlook and guidance
Full-year 2025 guidance maintained: revenue DKK 1,250–1,400 million, adjusted EBIT DKK 90–120 million, assuming full ownership of Celebert later in the year.
Cautious outlook due to geopolitical and macroeconomic uncertainty.
Latest events from TCM Group
- Q3 2024 saw strong B2C-driven growth, margin expansion, and improved earnings guidance.TCM
Q3 202419 Mar 2026 - 2025 revenue up 6.3% to DKK 1,279m, with Q4 up 10.5% and strong 2026 growth guidance.TCM
Q4 202526 Feb 2026 - Q2 revenue up 30% as B2C and AUBO drive growth; guidance raised, B2B remains weak.TCM
Q2 202423 Jan 2026 - B2C growth and margin gains drove 11% revenue rise, with positive 2025 outlook.TCM
Q4 20243 Dec 2025 - Q3 revenue up 4.1%, margins improved, Celebat/Celebert acquired, 2025 guidance narrowed.TCM
Q3 202525 Nov 2025 - Q2 revenue up 5.1%, EBIT up 20%, 2025 guidance narrowed amid softer demand and M&A activity.TCM
Q2 202523 Nov 2025